Scienture Holdings, Inc.

$0.39+0.62%(+$0.00)
TickerSpark Score
55/100
Mixed
68
Valuation
40
Profitability
55
Growth
80
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCNX research report →

52-Week Range7% of range
Low $0.24
Current $0.39
High $2.60

Companywww.trxadehealth.com

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies.

CEO
Shankar Hariharan
IPO
2014
Employees
14
HQ
Tampa, FL, US

Price Chart

-57.40% · this period
$2.60$1.42$0.24May 20Nov 18May 20

Valuation

Market Cap
$6.05M
P/E
-3.81
P/S
0.11
P/B
0.00
EV/EBITDA
89.07
Div Yield
0.00%

Profitability

Gross Margin
95.48%
Op Margin
-27.19%
Net Margin
-73.75%
ROE
-0.12%
ROIC
-0.02%

Growth & Income

Revenue
$431.61K · 215.87%
Net Income
$-41,512,264 · -557.90%
EPS
$-2.70 · -200.37%
Op Income
$-16,244,792
FCF YoY
-93632.98%

Performance & Tape

52W High
$2.60
52W Low
$0.24
50D MA
$0.40
200D MA
$0.67
Beta
3.17
Avg Volume
3.04M

Get TickerSpark's AI analysis on SCNX

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Feb 20, 26Shankar Hariharanother500,000
Oct 1, 25Shankar Hariharanother300,000
Apr 14, 25Shankar Hariharanother750,000
Sep 19, 24Shankar Hariharanother1,916,816
Mar 10, 25Shankar Hariharanother30,000
Sep 19, 24Shankar Hariharanother356,480
Sep 19, 24Shankar Hariharanother356,480
Feb 20, 26Narasimhan Maniother500,000
Sep 19, 24Narasimhan Maniother1,357,538
Mar 10, 25Narasimhan Maniother20,000

Our SCNX Coverage

We haven't published any research on SCNX yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate SCNX Report →

Similar Companies